News Headlines Article

Alzheimer’s startup snags yet another top Genentech exec
San Francisco Business Times

Startup Denali Therapeutics Inc. already has grabbed bright R&D and deal-making minds from biotech powerhouse Genentech Inc. So why not a financial whiz as well? The South San Francisco company, which is focusing on neurodegenerative diseases such as Alzheimer’s, Parkinson’s and ALS, or Lou Gehrig’s disease, said it will bring Genentech Chief Financial Officer Steve Krognes aboard Oct. 1.